» Articles » PMID: 2843999

The Ultrastructural Localization of Calcium-activated Protease "calpain" in Rat Brain

Overview
Journal Synapse
Specialty Neurology
Date 1988 Jan 1
PMID 2843999
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Calpain I, a calcium-activated neutral protease which degrades a number of cytoskeletal proteins, has been implicated in the rapid turnover of structural proteins that may participate in synaptic plasticity. In the present study, an antibody raised against purified erythrocyte calpain I was biochemically characterized and demonstrated to specifically bind the Mr = 80,000 subunit of both rat erythrocyte and brain calpain I. This antibody was used to examine the cellular distribution of calpain I at the electron microscopic level in rat brain and spinal cord using the avidin-biotin immunocytochemical technique. Reaction product was observed throughout neuronal perikarya, within both axonal and dendritic processes, and within spine heads and necks. Postsynaptic densities in both shaft and spine synapses were also immunoreactive. Glial cell bodies and processes were densely stained. In both neurons and glia, the reaction product was deposited along cytoskeletal elements. The localization of calpain I immunoreactivity to glial processes suggests this degradative enzyme may play a role in the glial hypertrophy and process retraction seen in brain. The presence of the enzyme in spines and postsynaptic densities is consistent with the hypothesis that it is involved in the turnover of synaptic cytoskeleton, thus providing a means through which transient physiological events effect lasting changes in the chemistry and morphology of spines.

Citing Articles

Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Baudry M, Bi X Trends Neurosci. 2016; 39(4):235-245.

PMID: 26874794 PMC: 4818674. DOI: 10.1016/j.tins.2016.01.007.


Calpain dysregulation in Alzheimer's disease.

Ferreira A ISRN Biochem. 2015; 2012:728571.

PMID: 25969760 PMC: 4393001. DOI: 10.5402/2012/728571.


Pharmacological enhancement of memory or cognition in normal subjects.

Lynch G, Cox C, Gall C Front Syst Neurosci. 2014; 8:90.

PMID: 24904313 PMC: 4033242. DOI: 10.3389/fnsys.2014.00090.


Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Wang Y, Briz V, Chishti A, Bi X, Baudry M J Neurosci. 2013; 33(48):18880-92.

PMID: 24285894 PMC: 3841454. DOI: 10.1523/JNEUROSCI.3293-13.2013.


Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Ma M Neurobiol Dis. 2013; 60:61-79.

PMID: 23969238 PMC: 3882011. DOI: 10.1016/j.nbd.2013.08.010.